Optometrists are invited to attend the launch of CooperVision’s latest innovation in myopia management – the MyDay MiSight 1 day contact lens – on Tuesday 10 March.
What to Expect
Global Insights
Dr Arthur Bradley, from CooperVision’s Global Research and Development team, will talk about the company’s approach to bringing effective, evidence-based myopia management to as many children as possible. He will explain how MyDay MiSight 1 day is designed to help protect against the worsening of myopia, how it performs, and what lies ahead.
Expert Perspectives
Hear from leading myopia management practitioners and their experience of MyDay MiSight 1 day in practice.
Connecting with Parents and Patients
Learn proven communication techniques from general practitioner and media personality, Dr Preeya Alexander, on building confidence and helping parents reach the best decision for their child.
Registration Essential
The incidence of myopia is increasing – early intervention is critical to help slow progression and protect children’s future eye health.*,1
Don’t miss this chance to elevate your clinical practice with innovative technology and more effective communication. Attend the launch event, titled Engaging families, shaping futures, on 10 March from 6pm at Voco Brisbane City Centre.
*Children with myopia ages 8-15 experienced slowed myopia progression when starting treatment with MiSight 1 day, which shares the same ActivControl technology with MyDay MiSight 1 day.
Reference
- Arumugam B et al. Modelling age effects of myopia progression for the MiSight 1 day clinical trial. IOVS. 2021;62(8):2333. CVI data on file, 2025.
